Los Angeles, California 90095

  • Prostate Cancer


Active Surveillance (A.S.) of prostate cancer (CaP) is the systematic monitoring of men with low-risk, localized lesions, with curative treatment of those whose tumors show substantial progression. A.S. is different from Watchful Waiting (W.W.), which is the palliative treatment of men with progressive prostate cancer.

Study summary:

This protocol is not designed as a formal clinical trial, but rather an observational protocol; no treatments and no randomization are included. Longitudinally, specimens and clinical data will be collected to provide information on the following: - Imaging studies of the prostate - Rates of curative intervention - Measures of tumor recurrence/progression - Disease specific survival - Overall survival - Clinical data to track Quality of Life


Inclusion Criteria: 1. Histologically confirmed adenocarcinoma of the prostate. 2. Clinically localized prostate cancer: T1-2, NX or N0, MX or M0. 3. No previous treatment for prostate cancer (including hormonal therapy, radiation therapy, surgery, or chemotherapy). 4. Patient has elected Active Surveillance as preferred management plan for prostate cancer. 5. Patient consent has been obtained according to local Institutional Review Board . 6. Patient is accessible and compliant for follow-up. Exclusion Criteria: 1. Unwillingness or inability to undergo serial prostate biopsy. 2. Overall life expectancy less than 2 years 3. Advanced prostate cancer



Primary Contact:

Principal Investigator
Leonard S Marks, M.D.
University of California, Los Angeles

Malu Macairan
Phone: (310) 794-3566
Email: mmacairan@mednet.ucla.edu

Backup Contact:

Email: lmarks@mednet.ucla.edu
Leonard S Marks, M.D.
Phone: (310) 794-3070

Location Contact:

Los Angeles, California 90095
United States

There is no listed contact information for this specific location.

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: September 18, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.